SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001558370-18-002951
Filing Date
2018-04-13
Accepted
2018-04-13 08:00:31
Documents
7
Period of Report
2018-05-15
Effectiveness Date
2018-04-13

Document Format Files

Seq Description Document Type Size
1 DEF 14A def14a.htm DEF 14A 780254
2 GRAPHIC def14ag001.jpg GRAPHIC 5826
3 GRAPHIC def14ag002.jpg GRAPHIC 5783
4 GRAPHIC def14ag003.jpg GRAPHIC 20309
5 GRAPHIC def14ag004.jpg GRAPHIC 5344
6 GRAPHIC def14ag005.gif GRAPHIC 60139
7 GRAPHIC def14ag006.gif GRAPHIC 48001
  Complete submission text file 0001558370-18-002951.txt   982349
Mailing Address 900 NORTHBROOK DRIVE, SUITE 200 TREVOSE PA 19053
Business Address 900 NORTHBROOK DRIVE, SUITE 200 TREVOSE PA 19053 (610) 254-9200
Strongbridge Biopharma plc (Filer) CIK: 0001634432 (see all company filings)

IRS No.: 981130690 | State of Incorp.: L2
Type: DEF 14A | Act: 34 | File No.: 001-37569 | Film No.: 18753192
SIC: 2834 Pharmaceutical Preparations